The human genome has been decoded. Of all the puzzles it contains, though, many remain unsolved. We know that the genome provides the blueprint for various proteins, the building blocks of each and every cell. But what role do they play? Which proteins control cell division in a healthy bod ... more
Max Planck Institute and Cellomics Announce Collaboration for High Content Screening Development
11-03-2005: The Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), located in Dresden, Germany, and Cellomics, a unit of Fisher Biosciences, recently announced a joint collaboration in the field of High Content Screening (HCS). The institute serves as a hub for numerous academic-industry collaborations in the field of HCS for drug discovery. Cellomics is recognized as the creator of HCS and is the market leader in the field. Cellomics provides a unique cell-based platform for its global clients in pharmaceutical, biotechnology, and academic institutions.
According to Daniel J. Calvo, President of Cellomics, the collaboration objectives include a mix of applications and new product development, as well as establishing a key demonstration center for Europe. "Max Planck is a perfect partner for us," stated Calvo. "They have tremendous experience and capabilities in this area and their strong ties to key academic centers across Europe are a real plus. This collaboration will provide valuable input to help drive the development of our product and applications portfolio for the growing academic market."
As part of the Agreement, MPI-MCBG has purchased the Cellomics' ArrayScan(R) VTI HCS Reader
along with its complete portfolio of BioApplications and HCi(TM) informatics software.
- Cellomics
- Max-Planck-Institut
- informatics
Pfotenhauerstr. 108
01307 Dresden
DEUTSCHLAND
- Phone
- +49351210-0
- Fax
- +49351210-2000
-
News
Cells may not have a mouth, but they still need to ingest substances from the external environment. If this process - known as endocytosis - is affected, it can lead to infectious diseases or cardio-vascular diseases, cancer, Huntington’s and diabetes. In cooperation with the Center for Inf ... more
Max Planck Institute and Cellomics Announce Collaboration for High Content Screening Development
The Max Planck Institute of Molecular Cell Biology and Genetics (MPI-CBG), located in Dresden, Germany, and Cellomics, a unit of Fisher Biosciences, recently announced a joint collaboration in the field of High Content Screening (HCS). The institute serves as a hub for numerous academic-ind ... more
- 1Schleicher & Schuell has been purchased by Whatman plc
- 2SCHOTT Instruments has changed its name to SI Analytics
- 3VWR International, LLC Signs Agreement to Acquire basan Germany GmbH
- 4SGS Minerals Services opens new lab in Chennai, India
- 5MDS Sciex Opens Manufacturing Facility in Singapore
- 6Sartorius opens new plant in India
- 7Affymetrix and eBioscience Amend Definitive Merger Agreement
- 8Fluidigm China Opens Its Doors
- 9Thermo Fisher Scientific Acquires NanoDrop Technologies
- 10PIAB announces new Chief Executive Officer
- Agilent Technologies and Universiti Putra Malaysia to Collaborate on Halal F ...
- Agilent Technologies and FDA Collaborate to Improve Testing for Salmonella
- Malvern Instruments and Postnova Analytics co-operate to deliver combined so ...
- Analytik Jena and SOTAX announce cooperation in dissolution systems
- Sartorius Stedim Biotech and Refine Technology Announce Cooperation
- Warnex launches two novel tests for Campylobacter and 24-hour Listeria -
- 90 Years of Sample Preparation with RETSCH -
- PerkinElmer Launches eLearning Initiative -
- Olympus Europe and MMI Molecular Machines & Industries announce exclusive distribution agreement - - 'Cutting edge' laser technology distribution agreement
- Danaher Announces Definitive Agreement to Acquire Leica Microsystems -





